Category: Research & Development
Research & Development market research reports by GlobalData
-
Pharmaceuticals - Enterprise ICT
Pharmaceuticals - Enterprise ICT Summary The Pharmaceuticals Enterprise ICT Country Intelligence Report, a new Vertical Intelligence Report by GlobalData, summarizes key findings from GlobalData’s ICT Customer Insight Survey carried out in H1-2024 and GlobalData’s Market Opportunity Forecasts to 202 ... Read More
-
Thematic Intelligence: The Future of Healthcare
Thematic Intelligence: The Future of Healthcare Summary This report is part of GlobalData's Future of Industry report series. It focuses on the healthcare sector.Several technologies will drive the future of healthcare. They include 3D printing, robotics, preventive medicine, and digital therapeutic ... Read More
-
Osteoporosis: Epidemiology Forecast to 2033
Osteoporosis: Epidemiology Forecast to 2033 Summary Osteoporosis is a disease in which the density and quality of bone are reduced over time. In a normal process known as remodeling, some of a person’s bone cells dissolve (resorption) and new bone cells grow back (formation). For people with osteopo ... Read More
-
Looking Ahead to 2024 - the Future of Pharma
Looking Ahead to 2024 - the Future of Pharma Summary This report provides a summary of the near and long-term future of the pharmaceutical industry from the standpoint of drug development. It provides a high-level analysis of key trends and movements within the industry via regulatory, clinical, an ... Read More
-
New Drug Approvals and Their Contract Manufacture - 2024 Edition
New Drug Approvals and Their Contract Manufacture - 2024 Edition Summary This report is the 14th edition of our long-running analysis of the CMO industry, using the FDA's NDA approvals as the primary indicator of performance. New Drug Approvals and Their Contract Manufacture (formerly called CMO Sco ... Read More
-
Clinical Trials: A Scorecard for Clinical Trial Investigations in 2023
Clinical Trials: A Scorecard for Clinical Trial Investigations in 2023 Summary This report provides an overview of global clinical trials with a start date between January 1, 2023, and December 31, 2023. Scope The clinical trials data used for these analyses were extracted from GlobalData’s Clinical ... Read More
-
Gout - Opportunity Assessment and Forecast
Gout - Opportunity Assessment and Forecast Summary The prevalence of gout is increasing at a steady rate, in line with population growth in the 7MM, at an AGR of 1.18%. Currently, the treatment regimen for gout in the 7MM is mostly limited to NSAIDs, corticosteroids, and ULTs with challenging safety ... Read More
-
Insomnia - Opportunity Assessment and Forecast
Insomnia - Opportunity Assessment and Forecast Summary This report covers the 7MM (US, France, Germany, Italy, Spain, UK, Japan) and provides an Excel-based forecast model for the insomnia market through 2032. Insomnia, currently represented in the International Classification of Sleep Disorders (Th ... Read More
-
Pharmaceuticals Industry Mergers and Acquisitions Deals by Top Themes in Q3 2023 - Thematic Intelligence
Pharmaceuticals Industry Mergers and Acquisitions Deals by Top Themes in Q3 2023 - Thematic Intelligence Summary This report analyzes the disruptive themes that have driven M&A activity in Q3 2023 in the Pharma Sector The global pharma sector in Q3 2023 witnessed deals worth $28 billion, a drop of 4 ... Read More
-
Mergers and Acquisitions (M&A) in the Contract Manufacturing Industry - Implications and Outlook - 2023 Edition
Mergers and Acquisitions (M&A) in the Contract Manufacturing Industry - Implications and Outlook - 2023 Edition Summary This report is the fourth edition of our analysis of mergers and acquisitions in the pharmaceutical contract manufacturing industry. PharmSource is the most definitive, trustworthy ... Read More
-
Pharmaceutical Drugs Development Annual Review, Sales and Forecast, Key Trends and Competitive Analysis
Pharmaceutical Drugs Development Annual Review, Sales and Forecast, Key Trends and Competitive Analysis Summary This report investigates the year 2022 in the pharmaceutical industry from the standpoint of drug development. It provides a high-level analysis of key trends and movements within the indu ... Read More
-
Brexit and the Healthcare Industry - Thematic Intelligence
Brexit and the Healthcare industry - Thematic Intelligence Summary In this report, GlobalData examines the business environment, weighs the challenges and opportunities, and assesses the risks that the UK’s healthcare sector is continuing to face post-Brexit. The report also highlights the impact fr ... Read More
-
Zollinger-Ellison Syndrome (Gastrinoma) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Zollinger-Ellison Syndrome (Gastrinoma) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Zollinger-Ellison Syndrome (Gastrinoma) Clinical Trial Analysis by Trial Phase, Tri ... Read More
-
Healthcare Expenditure and Pharmaceutical Sales by Region, Patent Expiries, New Technologies and Mergers and Acquisitions - Overview of 2022 and Outlook for 2023
Healthcare Expenditure and Pharmaceutical Sales by Region, Patent Expiries, New Technologies and Mergers and Acquisitions - Overview of 2022 and Outlook for 2023 Summary GlobalData is pleased to present an executive summary of healthcare expenditure and pharmaceutical sales forecasts from its Q1 202 ... Read More
-
Hidradenitis Suppurativa (HS) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Hidradenitis Suppurativa (HS) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in HS therapeutics. Synopsis In 2022, there will be more than three million diagnosed p ... Read More
-
Jordan Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape
Jordan Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape Summary GlobalData, the industry analysis specialist, has released its latest report “Jordan Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Comp ... Read More
-
Alzheimer Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Alzheimer Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update Summary GlobalData's Medical Devices sector report, “Alzheimer Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path an ... Read More
-
Denmark Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape
Denmark Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape Summary GlobalData, the industry analysis specialist, has released its latest report “Denmark Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Co ... Read More
-
Sweden Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape
Sweden Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape Summary GlobalData, the industry analysis specialist, has released its latest report “Sweden Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Comp ... Read More
-
Coronavirus Disease 2019 (COVID-19) Impact on Clinical Trials, 2022 Update
Coronavirus Disease 2019 (COVID-19) Impact on Clinical Trials, 2022 Update Summary This 55-page PowerPoint based report gives an important update to the previous year with an expert analysis on how COVID-19 is impacting clinical trials and the potential move toward decentralized clinical trials. Fin ... Read More
-
Coronavirus Disease 2019 (COVID-19) Clinical and Commercial Analyzer - August 2022
Coronavirus Disease 2019 (COVID-19) Clinical and Commercial Analyzer - August 2022 Summary The Coronavirus Disease 2019 (COVID-19) Clinical and Commercial Analyzer looks at the data from clinical trials for vaccines and therapeutics either currently marketed or in the pipeline. The data is assessed, ... Read More
-
Immuno-oncology Market Size, Share, Trends, Analysis and Forecast by Region, Segment, Type (Checkpoint Modulators, Cancer Vaccines) and End-User (Hospitals, Cancer Research Institute), 2022-2030
Immuno-oncology Market Size, Share, Trends, Analysis and Forecast by Region, Segment, Type (Checkpoint Modulators, Cancer Vaccines) and End-User (Hospitals, Cancer Research Institute), 2022-2030 Summary The immuno-oncology market size was valued at US$45.12 billion in 2021 and is expected to grow at ... Read More
-
Niemann-Pick Type C Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
Niemann-Pick Type C Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 Summary The prevalence of Niemann Pick Type C (NPC) is increasing at a steady rate, in line with population growth in t ... Read More
-
Myelofibrosis Epidemiology Analysis and Forecast, 2021-2031
Myelofibrosis Epidemiology Analysis and Forecast, 2021-2031 Summary Myelofibrosis (MF) belongs to a group of diseases called myeloproliferative disorders. MF is a serious bone marrow disorder that disrupts the body’s normal production of blood cells (MedlinePlus, 2020; Mayo Clinic, 2021). MF include ... Read More
-
Diabetic Macular Edema Epidemiology Analysis and Forecast, 2021-2031
Diabetic Macular Edema Epidemiology Analysis and Forecast, 2021-2031 Summary Macular edema (ME) is a condition characterized by the thickening and swelling (edema) of the macula, which is the area of the retina that is responsible for central vision. The pathogenesis of ME is complex and multifactor ... Read More
Research Assistance
